Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Change in Acquisitions & Divestments (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $132.1 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 57.43% to $132.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $462.3 million through Dec 2025, up 2.71% year-over-year, with the annual reading at $462.3 million for FY2025, 2.71% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $132.1 million at Nuvation Bio, up from $78.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $244.2 million in Q2 2023, with the low at $78.5 million in Q3 2025.
  • Average Change in Acquisitions & Divestments over 3 years is $135.4 million, with a median of $123.7 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments plummeted 53.88% in 2024, then surged 57.43% in 2025.
  • Over 3 years, Change in Acquisitions & Divestments stood at $181.9 million in 2023, then tumbled by 53.88% to $83.9 million in 2024, then skyrocketed by 57.43% to $132.1 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $132.1 million, $78.5 million, and $136.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.